Cardiol Therapeutics (OTCMKTS:CRTPF) Shares Down 3.5% – Here’s What Happened - American Market News
Author: ABMN Staff
Description: Read Cardiol Therapeutics (OTCMKTS:CRTPF) Shares Down 3.5% – Here’s What Happened at American Market News
Keywords: Cardiol Therapeutics,OTCMKTS:CRTPF,CRTPF,Medical,Stocks,Technicals
Date: 2026-06-10T01:10:57+0000

Skip to main content

# Cardiol Therapeutics (OTCMKTS:CRTPF) Shares Down 3.5% – Here’s What Happened

Posted by ABMN Staff on Jun 10th, 2026

Share on Twitter
Share on Facebook
Share on LinkedIn
Share on Stocktwits

Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s share price fell 3.5% during trading on Tuesday . The stock traded as low as $1.0950 and last traded at $1.11. 427,366 shares were traded during mid-day trading, an increase of 537% from the average session volume of 67,097 shares. The stock had previously closed at $1.15.

Get Cardiol Therapeutics alerts:

## Cardiol Therapeutics Stock Down 3.5%

The company has a 50 day moving average price of $1.34 and a 200 day moving average price of $1.13.

## Cardiol Therapeutics Company Profile

(Get Free Report)

Cardiol Therapeutics Inc is a clinical-stage biotechnology company focused on the development of novel immuno-lipid therapies for treating heart failure and inflammation-related cardiovascular diseases. The company’s proprietary platform is built on synthetic formulations of cardiolipin, a naturally occurring mitochondrial lipid known to play a key role in cellular energy production and inflammatory regulation. By harnessing the anti-inflammatory properties of cardiolipin derivatives, Cardiol aims to address unmet needs in acute and chronic cardiovascular conditions.

Cardiol’s lead product candidate, CT-1 Microspheres, is designed for intravenous administration to hospitalized patients with acute decompensated heart failure.

## Featured Stories

- Five stocks we like better than Cardiol Therapeutics
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer

Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

## You might be interested in:

Patrick Ryan Buys 120,000 Shares of Ryan Specialty Stock
David Duffield Sells 107,500 Shares of Workday Stock
James Stanley Anderson Sells 10,000 Shares of Steel Dynamics Stock
Traders Purchase Large Volume of Call Options on Planet Labs PBC
Jay Horgen Sells 17,500 Shares of Affiliated Managers Group Stock
Madison Dearborn Partners Llc Sells 2,273,843 Shares of AEVEX Stock